Medicilon in one place
Dive Deeper
Corporate News
- Corporate News
Medicilon Congratulates : MindRank AI-Developed Oral GLP-1 MDR-001 Secures Up to RMB 1.75 Billion Exclusive Commercialization Deal with Sunshine Mandi
- Corporate News
A Note of Appreciation, A Mark of Recognition | Medicilon Supports Partner Tasly in Obtaining Clinical Trial Approval for TSL2402 Tablets
- Corporate News
【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026
- Corporate News
Medicilon’s Formulation CDMO Platform Advances Taiji Group’s Next-Generation RNA Polymerase Inhibitor DSC158A Tablets to Clinical Stage
- Corporate News
TPD CN-US Dual Filing Milestone: Medicilon’s One-Stop Platform Helps Gluetacs Secure Dual Approval for GT818, a First-in-Class RSK Degrader
- Corporate News
World’s First Long-Acting Anti-RSV Monoclonal Antibody Xinduotuo Wins NMPA Approval — Medicilon Empower Trinomab’s Source Innovation
Events
- Events
Oct. 7 (Wed.) - 9 (Fri.), 2026 10:00-17:00. Venue, PACIFICO Yokohama.
BIOJAPAN 2026
- Events
Basel, Switzerland from September 6-10, 2026
EFMC-ISMC 2026
- Events
Date: August 27-28, 2026
Venue:The Westin Seoul Parnas, South Korea - Medicilon Booth #6
Venue:The Westin Seoul Parnas, South Korea - Medicilon Booth #6
4th SMC and AimedBio ADC Conference
- Events
Date: August 23-27, 2026
Venue: McCormick Place Convention Center, Chicago, IL - Medicilon Booth #400
Venue: McCormick Place Convention Center, Chicago, IL - Medicilon Booth #400
ACS Fall 2026
- Events
Date: September 10, 2026 (Thursday)
Venue: EL Tower, Ruby Hall, Yangjae, Seoul
Venue: EL Tower, Ruby Hall, Yangjae, Seoul
【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026
- Events
July 28th, 2026
6:00-7:00 PM (PST) | 9:00-10:00 PM (EST)
6:00-7:00 PM (PST) | 9:00-10:00 PM (EST)
Medicilon Webinar | IND-enabling Toxicity Studies, CTD Documentation and Translational Cardiac Risk Assessment
Medicilon Academy
- Medicilon Academy
【Case Study】New Approach Methods NAMs
- Medicilon Academy
【Case Study】Route, Solid-State, and Impurity Optimization (Small-Molecule API)
- Medicilon Academy
【Case Study】IND Completion in 12 Months (Small-Molecule NCE)
- Medicilon Academy
Boston Non-Tumor Models Innovation
- Medicilon Academy
【White Paper】Navigating the DMPK Gauntlet: A Strategic Analysis of the Interconnected Challenges Shaping the Future of Drug Development
- Medicilon Academy
【White Paper】Patient-Derived Xenograft Organoids: Advancements and Applications in Precision Oncology
Digital Materials
- Digital Materials
A Sensitive LC–MS Bioanalytical Method for Simultaneous Quantification of Structurally Similar Cyclic Tetrapeptides at the Picogram Level (Download)
- Digital Materials
Quantification of antibody-Conjugated Drug in Cleavable ADCs: A Universal, Automated, and Cost-Effective LC-MS/MS Platform (Download)
- Digital Materials
Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)
- Digital Materials
Integrated Mass Spectrometric Workflows Enabling Next-Generation Conjugate Therapeutics in Cancer Research (Download)
- Digital Materials
From Sequence Design to AOC Production Medicilon’ s End-to-End RNAi Development Platform (Download)
- Digital Materials
